Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts

Blood

Volumn 123, Issue 10, 2014, Pages 1556-1563

  Van Bladel, Esther R ^a   Laarhoven, Annemieke G ^b   Van Der Heijden, Laila B ^c   Heitink Pollé, Katja M ^c   Porcelijn, Leendert ^b   Van Der Schoot, C Ellen ^b   De Haas, Masja ^b   Roest, Mark ^a   Vidarsson, Gestur ^b   De Groot, Philip G ^a   Bruin, Marrie C A ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CONVULXIN; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBIN RECEPTOR ACTIVATOR PEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLEEDING; CELL ISOLATION; CELL STIMULATION; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRANULATION; FEMALE; FUNCTION TEST; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; MICROAGGREGATION TEST; PHENOTYPE; PLATELET REACTIVITY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADOLESCENT; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REPRODUCIBILITY OF RESULTS; TETRADECANOYLPHORBOL ACETATE;

EID: 84897496536     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-08-519686     Document Type: Article

References (23)

1. Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol. 2010;134(6):955-963.
2. Rand ML, Leung R, Packham MA. Platelet function assays. Transfus Apheresis Sci. 2003;28(3):307-317. (Pubitemid 36506506)
3. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990;16(1):1-20. (Pubitemid 20049639)
4. Picker SM. In-vitro assessment of platelet function. Transfus Apheresis Sci. 2011;44(3):305-319.
5. Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR; Intercontinental Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001;358(9299):2122-2125. (Pubitemid 34094903)
6. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174-180.
7. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37(3):239-248. (Pubitemid 30612902)
8. Newland AC, Macey MG. Immune thrombocytopenia and Fc receptor-mediated phagocyte function. Ann Hematol. 1994;69(2):61-67. (Pubitemid 24266964)
9. Perdomo J, Yan F, Chong BH. A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production. Platelets. 2013;24(2):98-106.
10. Grace RF, Long M, Kalish LA, Neufeld EJ. Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population. Pediatr Blood Cancer. 2012;58(2):216-220.
11. Neunert CE, Buchanan GR, Imbach P, et al; Intercontinental Cooperative ITP Study Group Registry II Participants. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013;121(22):4457- 4462.
12. De Cuyper IM, Meinders M, van de Vijver E, et al. A novel flow cytometry-based platelet aggregation assay. Blood. 2013;121(10):e70-e80.
13. Bonnefoy A, Yamamoto H, Thys C, Kito M, Vermylen J, Hoylaerts MF. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha. Blood. 2003;101(4):1375-1383. (Pubitemid 36182509)
14. Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ. Laboratory diagnosis and molecular classification of von Willebrand disease. Acta Haematol. 2009;121(2-3):71-84.
15. van Bladel ER, Roest M, de Groot PG, Schutgens RE. Up-regulation of platelet activation in hemophilia A. Haematologica. 2011;96(6):888-895.
16. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr. 2002;141(5):683-688. (Pubitemid 35292768)
17. Porcelijn L, Huiskes E, Maatman R, de Kreuk A, de Haas M. Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases. Vox Sang. 2008;95(4):324-330.
18. Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood. 1996;88(1):194-201. (Pubitemid 26230687)
19. Hagenström H, Schlenke P, Hennig H, Kirchner H, Klüter H. Quantification of platelet-associated IgG for differential diagnosis of patients with thrombocytopenia. Thromb Haemost. 2000;84(5):779-783.
20. Warner MN, Moore JC, Warkentin TE, Santos AV, Kelton JG. A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura. Br J Haematol. 1999;104(3):442-447. (Pubitemid 29119263)
21. Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci. 1998;19(3):237-244.
22. Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013;121(14):2596-2606.
23. Siebers RW, Wakem PJ, Carter JM. Long-term intra-individual variation of platelet parameters. Med Lab Sci. 1989;46(1):77-78. (Pubitemid 19060289)